KEGG   DRUG: D08936Help
Entry
D08936                      Drug                                   
Name
Labetuzumab (INN/USAN)
Activity
Treatment of colorectal cancer [humanized monoclonal antibody hMN-14 targeting CEA-positive cancer]
Target
Brite
Target-based classification of drugs [BR:br08310]
 Others
  Cellular antigens
   CD66 (CEACAM) [HSA:1048 1084 1087 1088 1089 4680 634 90273] [KO:K06499]
    Labetuzumab
     D08936  Labetuzumab (INN/USAN)
BRITE hierarchy
Other DBs
CAS: 
219649-07-7
PubChem: 

» Japanese version   » Back
DBGET integrated database retrieval system